Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)

the AXSANA Study Group, Steffi Hartmann*, Maggie Banys-Paluchowski, Tomasz Berger, Nina Ditsch, Elmar Stickeler, Jana de Boniface, Oreste Davide Gentilini, Jennifer Schroth, Guldeniz Karadeniz Cakmak, Isabel T. Rubio, Maria Luisa Gasparri, Michalis Kontos, Eduard Alexandru Bonci, Laura Niinikoski, Dawid Murawa, Geeta Kadayaprath, David Pinto, Florentia Peintinger, Ellen SchlichtingLukas Dostalek, Helidon Nina, Hagigat Valiyeva, Marian Vanhoeij, Andraž Perhavec, Douglas Zippel, Lia Pamela Rebaza, Sarun Thongvitokomarn, Sarah Fröhlich, Franziska Ruf, Angelika Rief, Kristina Wihlfahrt, Timo Basali, Marc Thill, Michael Patrick Lux, Sibylle Loibl, Hans Christian Kolberg, Jens Uwe Blohmer, Markus Hahn, Meryem Gunay Gurleyik, Mauro Porpiglia, Semra Gunay, Linda Zetterlund, Thorsten Kuehn, Agnieszka Kolacinska-Wow, Alberto Silva, Alessandro Fancellu, Alexander Hein, Dorothea Fischer, Frederik Felipe Fromm, Telja Pursche

*Korrespondierende/r Autor/-in für diese Arbeit
2 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medicine and Dentistry

Immunology and Microbiology